Walleye Capital
EVH icon

Walleye Capital’s Evolent Health EVH Stock Holding History

Walleye Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.58M Buy
845,787
+709,839
+522% +$2.72M 0.02% 880
2026
Q1 		$310K Sell
135,948
-2,784
-2% -$8.83K ﹤0.01% 3040
2025
Q4 		$555K Sell
138,732
-515,729
-79% -$2.87M ﹤0.01% 2895
2025
Q3 		$5.54M Buy
654,461
+6,700
+1% +$65K 0.02% 871
2025
Q2 		$7.29M Buy
647,761
+595,458
+1,138% +$5.47M 0.03% 660
2025
Q1 		$495K Buy
52,303
+48,689
+1,347% +$492K ﹤0.01% 2570
2024
Q4 		$40.7K Buy
3,614
+678
+23% +$11.9K ﹤0.01% 4406
2024
Q3 		$83K Sell
2,936
-5,512
-65% -$142K ﹤0.01% 4472
2024
Q2 		$162K Buy
+8,448
New +$216K ﹤0.01% 4448
2021
Q4 		– Sell
-27,662
Closed -$858K – 2163
2021
Q3 		$858K Buy
+27,662
New +$664K 0.02% 535
2019
Q4 		– Sell
-49,368
Closed -$355K – 1921
2019
Q3 		$355K Buy
49,368
+20,597
+72% +$148K 0.02% 900
2019
Q2 		$229K Buy
+28,771
New +$341K 0.03% 891

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Walleye Capital's EVH Position: Q2 2026 in Review

Walleye Capital increased its Evolent Health (EVH) stake by 522% in Q2 2026, buying an estimated $2.72M and bringing the position to 845,787 shares worth $4.58M. The position accounts for 0.02% of the portfolio, ranked #880.

Walleye Capital first reported a position in EVH in Q2 2019 and has held it in 12 quarters since. The position peaked at $7.29M in Q2 2025. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Walleye Capital held 845,787 shares of Evolent Health worth $4.58M as of Q2 2026.
  • Walleye Capital bought 709,839 Evolent Health shares in Q2 2026, an estimated $2.72M.
  • Evolent Health made up 0.02% of Walleye Capital's portfolio in Q2 2026, its #880 holding.
  • Walleye Capital first reported a position in Evolent Health in Q2 2019 and has held it in 12 quarters since.
  • Walleye Capital's Evolent Health position peaked at $7.29M in Q2 2025.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.